Sanofi, Teva say study results show gut disease drug could be ‘best in class’

cafead

Administrator
Staff member
  • cafead   Dec 17, 2024 at 12:12: PM
via Phase 2 results hinted the partners’ therapy could be more potent than similar inflammatory bowel disease medicines from Merck and Roche.

article source